v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (8,366,642) $ (1,148,255)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expenses 73,184 55,067
Amortization of operating right-of-use assets 267,701 252,730
Share-based compensation 6,104,672 0
Changes in NAV of investment securities 741,482 0
Loss from equity method investment 31,603 341,428
Deferred income taxes 0 (77,138)
Changes in operating assets and liabilities:    
Receivables from clients, including related parties (13,686,266) 9,159,102
Receivables from broker-dealers and clearing organization (7,480,846) (1,004,214)
Receivables from software licensing and related support services 30,839 (260,370)
Receivables and contract assets from software licensing and related support services, including related parties (661,684) 0
Prepaid expenses and other current assets (266,110) (901,037)
Other assets 29 217,523
Payables to clients, including related parties 16,243,500 (9,143,454)
Payables to broker-dealers and clearing organization 4,991,750 24,677
Accrued expenses and other current liabilities 52,348 (304,038)
Amounts due to related parties 762,213 507,822
Operating lease liabilities (282,432) (267,405)
Net cash used in operating activities (1,444,659) (2,547,562)
Cash flows from investing activities:    
Purchase of property and equipment (278,515) (7,081)
Purchase of investment securities, at NAV, including related party (2,100,000) 0
Net cash used in investing activities (2,378,515) (7,081)
Cash flows from financing activities:    
Proceeds from bank overdrafts 1,580,583 0
Repayment of borrowings from a related party (19,177) (1,800,000)
Payment for deferred offering costs (280,700) (96,484)
Proceeds from initial public offering, net of underwriting discount 18,515,000 0
Principal payment for finance lease (1,535) (2,036)
Net cash provided by (used in) financing activities 19,794,171 (1,898,520)
Effect of exchange rate changes 11,688 48,549
Net increase (decrease) in cash, cash equivalents and cash segregated under regulatory requirements 15,982,685 (4,404,614)
Cash, cash equivalents and cash segregated under regulatory requirements at the beginning of the period 13,900,319 10,652,186
Cash, cash equivalents and cash segregated for regulatory requirements at the end of the period 29,883,004 6,247,572
Reconciliation of cash, cash equivalents and cash segregated under regulatory requirements    
Cash and cash equivalents 14,347,536 3,053,691
Cash segregated under regulatory requirements 15,535,468 3,193,881
Cash, cash equivalents and cash segregated under regulatory requirements at the end of period 29,883,004 6,247,572
Supplemental disclosure of cash flow information:    
Income taxes paid 0 0
Interest paid 332,373 60,051
Supplemental schedule of non-cash investing and financing activities    
Non-cash deferred offering costs offset against accrued expenses 1,341,321 0
Other receivables from disposal of equity method investment 899,639 0
Obtaining operating right-of-use assets in exchange for operating lease liabilities 0 977,696
Non-cash settlement of receivable from software licensing and related support services - related party offset against payables to clients - related party $ 0 $ 330,580